Alternating intravenous racemic ketamine and electroconvulsive therapy in treatment resistant depression: A case report

被引：0
|
作者：
Bartova, L. [1 ]
Weidenauer, A. [1 ]
Dold, M. [1 ]
Naderi-Heiden, A. [1 ]
Kasper, S. [1 ]
Willeit, M. [1 ]
Praschak-Rieder, N. [1 ]
机构：
[1] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.693
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EV0363
引用
收藏
页码：S522 / S522
页数：1
相关论文
共 50 条
  • [31] Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression
    Zhong, Xiaomei
    He, Hongbo
    Zhang, Chunping
    Wang, Zhijie
    Jiang, Miaoling
    Li, Qirong
    Zhang, Minling
    Huang, Xiong
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 201 : 124 - 130
  • [32] The effect of ketamine anesthesia on the efficacy of electroconvulsive therapy and cognitive functions in treatment-resistant depression
    Bodnar, A.
    Ferensztajn, E.
    Krzywotulski, M.
    Bartkowska-Sniatkowska, A.
    Lewandowska, A.
    Chlopocka-Wozniak, M.
    Rybakowski, J. K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S434 - S435
  • [33] Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Voort, Jennifer Vande
    Han, Xianlin
    Port, John
    Frye, Mark
    Daouk, Rima Kaddurah
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 192 - 192
  • [34] Lipidomic Signatures Inform Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Feasibility Trial
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Voort, Jennifer Vande
    Han, Xianlin
    Port, John
    Frye, Mark
    Kaddurah-Daouk, Rima
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S23 - S24
  • [35] Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Vande Voort, Jennifer
    Han, Xianlin
    Port, John
    Frye, Mark
    Daouk, Rima Kaddurah
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 192 - 192
  • [36] Combined administration of oral tranylcypromine and intravenous S-ketamine in treatment-resistant depression: A case report
    Bartova, L.
    Vogl, S. E.
    Stamenkovic, M.
    Praschak-Rieder, N.
    Naderi-Heiden, A.
    Kasper, S.
    Willeit, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S270 - S271
  • [37] Ketamine Noninferior to Electroconvulsive Therapy for Depression
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (23): : 2011 - 2012
  • [38] Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study
    Halpape, Katelyn
    Pashovitz, Raelle
    Wanson, Annabelle
    Hooper, Monika
    Peters, Evyn M.
    BMC PSYCHIATRY, 2025, 25 (01)
  • [39] Kynurenine pathway metabolism and the neurobiology of treatment resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy
    Allen, A. P.
    Naughton, M.
    Dowling, J.
    Walsh, A.
    O'Shea, R.
    Shorten, G.
    Scott, L.
    McLoughlin, D. M.
    Cryan, J. F.
    Clarke, G.
    Dinan, T. G.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 100 : 24 - 32
  • [40] Combination therapy utilizing ketamine and transcranial magnetic stimulation for treatment-resistant depression: a case report
    Best, Steven Richard Devore
    Griffin, Brian
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2015, 125 (03) : 232 - 234
12345